We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current IPSC market cap is 197.18M. The company's latest EPS is USD -1.6497 and P/E is -1.44.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.72M | 99k | 148k | 268k | 855k |
| Operating Income | -32.08M | -30.86M | -39.85M | -27.4M | -31.31M |
| Net Income | -31.26M | -33.29M | -32.72M | -39.4M | -28.06M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 5.2M | 2.24M |
| Operating Income | -239.68M | -53.9M | -94.88M | -133.83M | -130.18M |
| Net Income | -238.77M | -53.58M | -95.82M | -130.93M | -136.67M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 456.23M | 417.16M | 397.55M | 360.69M | 348.51M |
| Total Liabilities | 179.05M | 169.59M | 178.32M | 175.94M | 170.62M |
| Total Equity | 277.18M | 247.57M | 219.23M | 184.75M | 177.88M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 90.9M | 106.78M | 437.38M | 486.54M | 360.69M |
| Total Liabilities | 2.99M | 33.43M | 41.14M | 183.81M | 175.94M |
| Total Equity | -91.86M | -106.41M | 396.24M | 302.74M | 184.75M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -29.22M | -48.47M | -62.12M | -88.35M | -30.25M |
| Investing | 31.34M | 38.31M | 42.53M | 61.13M | 11.54M |
| Financing | 448k | -9.67M | -9.37M | -9.73M | 18.2M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -11.77M | -41.27M | -89M | 14.05M | -88.35M |
| Investing | -19.01M | -22.76M | -298.34M | -13.13M | 61.13M |
| Financing | 74.84M | 47.69M | 417.77M | 27.16M | -9.73M |
| Market Cap | 197.18M |
| Price to Earnings Ratio | -1.44 |
| Price to Sales Ratio | 88.15 |
| Price to Cash Ratio | 4.17 |
| Price to Book Ratio | 1.07 |
| Dividend Yield | - |
| Shares Outstanding | 82.85M |
| Average Volume (1 week) | 206.37k |
| Average Volume (1 Month) | 380.03k |
| 52 Week Change | -24.68% |
| 52 Week High | 5.51 |
| 52 Week Low | 1.28 |
| Spread (Intraday) | 0.73 (24.75%) |
| Company Name | Century Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.centurytx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
